Our mission is to unite and align key diabetes stakeholders and the larger diabetes community around key
diabetes-related policy and legislative efforts in order to elevate diabetes on the national agenda.

Healthy People 2020

The Diabetes Advocacy Alliance (DAA) and the United States Department of Health and Human Services (HHS), Office of Disease Prevention and Health Promotion (ODPHP), have a 10-year strategic partnership, which was announced on November 19, 2012.

This partnership works to help advance Healthy People 2020 diabetes objectives related to prevention and treatment through:

  • Coordination of activities that promote awareness of diabetes prevention or prevention of complications from diabetes;
  • Facilitation of data collection to monitor progress toward achievement of Healthy People 2020 diabetes objectives; and
  • Support for cross-sector collaboration to affect policy and system changes.

The Healthy People 2020 program provides science-based, 10-year national objectives for improving the health of all Americans. For three decades, Healthy People has established benchmarks and monitored progress over time in order to:

  • Encourage collaborations across communities and sectors;
  • Empower individuals toward making informed health decisions; and
  • Measure the impact of prevention activities.

Examples of DAA Collaboration with Healthy People 2020

On February 21st, 2017 the DAA co-hosted a webinar with the HHS Office of Disease Prevention and Health Promotion (ODPHP). The webinar, “Improving Diabetes Screening and Referral to Prevention Programs: A Healthy People 2020 Spotlight on Health Webinar,” featured leading subject matter experts and evidence-based programs and resources. The goal of the webinar was to educate interested stakeholders on the importance of screening, for both prediabetes and diabetes, and referral to diabetes prevention program.

Webinar presenters included: Dr. Ed Gregg, Centers for Disease Control and Prevention; Dr. Quyen Ngo-Metzger, Agency for Healthcare Research and Quality; Carlye Burd, Center for Medicare and Medicaid Innovation; Dr. Ronald Ackermann, Northwestern University Feinberg School of Medicine; and Dr. Andrea Caracostis, Hope Clinic in Houston, Texas.

A recording of the full webinar is available here.

On September 20th, 2016 the DAA co-hosted a meeting with the HHS Office of Disease Prevention and Health Promotion (ODPHP) as part of DAA's strategic partnership with the office to help advance Healthy People 2020 Diabetes Objectives. The focus of the meeting was on "Optimal Outcomes to Prevent Diabetes: Consideration of Screening Quality Measures."

Meeting participants included representatives from the following federal health agencies: the Agency for Healthcare Research and Quality, Centers for Disease Control and Prevention, Health Resources and Services Administration, Indian Health Service, National Diabetes Education Program, and National Institutes of Health.

After formal presentations from the National Quality Forum, U.S. Preventive Services Task Force (USPSTF), and the American Medical Assocation, DAA members and federal health agency representatives had a robust discussion about next steps and potential collaboration in support of quality measures for prediabetes/diabetes screening and referral to diabetes prevention programs (DPP). There was a strong interest and support from all stakeholders to pursue quality measurement of screening and DPP referral.

On April 19, 2016, DAA members met with a number of federal agency representatives with interests in achieving the Healthy People 2020 objectives for diabetes. During the meeting, information was exchanged about diabetes screening and new research was shared. Topics covered during the meeting included:

  • Review of the new U.S. Preventive Services Task Force (USPSTF) diabetes screening recommendation
  • Insights into physician attitudes and practices related to screening their patients for diabetes
  • Public understanding of clinical preventive services guidelines
  • Updates from the Centers for Disease Control and Prevention (CDC) on its National Diabetes Prevention Program, CDC’s 6/18 Initiative, the CDC and AMA “Prevent Diabetes STAT” initiative, and the new prediabetes awareness campaign sponsored by ADA, AMA, CDC and The Ad Council
  • Lessons learned from the Centers for Medicare and Medicaid Innovation (CMMI) grant to the YMCA of the USA regarding enrolling seniors in Medicare in community-based diabetes prevention programs
  • Updates from the American Association of Diabetes Educators (AADE), Weight Watchers International and Omada Health about their respective diabetes prevention programs

View Past Activities